NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that its third quarter revenues rose 8 percent year over year, thanks largely to a 13 percent increase in reported revenues from its diagnostics business.

For the three months ended Oct. 1, the firm reported total revenues of $554.3 million, up from $514.5 million a year earlier, beating Wall Street analyst expectations for revenues of $552.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.